ARA-290 Nasal Spray
Stackpure provides ARA-290 Nasal Spray for neuropathic pain, metabolic syndrome neuropathy, and tissue repair research. This research-grade nasal spray is a non-erythropoietic cyclic peptide that selectively activates the innate repair receptor (IRR), driving tissue protection and anti-inflammatory signalling without erythropoietic side effects. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.
For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.
Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.
ARA-290 Nasal Spray is a research-grade nasal spray supplied by Stackpure for laboratory investigation. ARA-290 is studied in the context of tissue repair, wound healing, and musculoskeletal recovery. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.
What Is ARA-290?
ARA-290 is a compound that has attracted significant interest in preclinical research examining tissue repair, wound healing, and musculoskeletal recovery. Scientists investigating ARA-290 have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.
Stackpure provides ARA-290 Nasal Spray for researchers requiring verified, traceable material. The nasal spray format enables transmucosal delivery for research protocols requiring alternative administration routes. Researchers may also be interested in ARA-290 Peptide Vial, which provides the same compound in an alternative format.
this nasal spray Research Applications
Preclinical studies involving this nasal spray have explored the following areas:
- Tissue regeneration: Studies have examined the role of this compound in accelerating repair of damaged connective tissue, tendons, and ligaments.
- Wound healing: Preclinical models have investigated angiogenic and fibroblast-stimulating properties relevant to dermal and mucosal wound repair.
- Musculoskeletal support: Research has explored protective and regenerative effects on muscle, bone, and cartilage under injury conditions.
These directions reflect the broad scientific interest in ARA-290 and the growing body of literature examining its potential applications in research contexts.
Stackpure's nasal spray Quality Standards
Every this nasal spray supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure nasal spray receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.
- Purity: +99% by HPLC analysis
- Facility: cGMP-certified manufacturing
- Testing: Identity, purity, and potency verified per batch
- Documentation: COA available for every order
This analytical rigour ensures that researchers working with Stackpure's nasal spray can maintain experimental consistency and reproducibility across studies.
Research Use Disclaimer
Independent Lab Verification
Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.
this nasal spray from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving this nasal spray must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.
Working with the nasal spray format
- Supplied as a ready-to-use solution in a metered spray bottle, so there is no reconstitution step.
- Intended for intranasal delivery models only. It is not a substitute for an injectable preparation and should not be used as one.
- Delivery depends on the metered volume per actuation, so record the number of actuations in your protocol.
- Keep the bottle capped, upright and refrigerated, away from direct light and heat.
Research Questions
What is ARA-290 Nasal Spray used for in research?
this nasal spray is a research-grade nasal spray studied for neuropathic pain, metabolic syndrome neuropathy, and tissue repair research. It acts as a non-erythropoietic cyclic peptide that selectively activates the innate repair receptor (IRR), driving tissue protection and anti-inflammatory signalling without erythropoietic side effects. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.
How does ARA-290 Nasal Spray work?
this nasal spray is a non-erythropoietic cyclic peptide that selectively activates the innate repair receptor (IRR), driving tissue protection and anti-inflammatory signalling without erythropoietic side effects. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on neuropathic pain outcomes.
What research dosage is used for ARA-290 Nasal Spray?
Phase II trials used 4 mg/day subcutaneous administration over 28 days. All dosage information is from pre-clinical or research contexts only. this nasal spray is sold exclusively for research use and is not approved for human consumption.
How does ARA-290 Nasal Spray compare to related research compounds?
this nasal spray is frequently studied alongside Erythropoietin (EPO) derivatives and BPC-157 for tissue protection research. Its innate repair receptor agonist classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.
Where can I buy ARA-290 Nasal Spray for research purposes?
Stackpure supplies this nasal spray as a research-grade nasal spray with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.
What does the Certificate of Analysis verify for ARA-290 Nasal Spray?
A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this nasal spray is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.